Yayın:
A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEbru Zeytün
dc.contributor.authorZeytün, Ebru
dc.contributor.authorMehlika Dilek Altıntop
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorBelgin Sever
dc.contributor.authorALTINTOP, MEHLİKA DİLEK
dc.contributor.authorAhmet Özdemır
dc.contributor.authorÖZDEMİR, AHMET
dc.contributor.authorDoha El‐Sayed Ellakwa
dc.contributor.authorZeynep Ocak
dc.contributor.authorHalil I. Ciftci
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorMohamed O. Radwan
dc.contributor.orcid0000-0002-1783-527X
dc.contributor.orcid0000-0002-8159-663X
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0003-0280-5550
dc.contributor.orcid0000-0003-4824-3485
dc.contributor.orcid0000-0002-5954-5086
dc.contributor.orcid0000-0002-9796-7669
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.date.accessioned2025-11-13T10:15:04Z
dc.date.issued2020-08-25
dc.identifier.doi10.2174/1871520620666200824100408
dc.identifier.endpage1109
dc.identifier.issn1871-5206
dc.identifier.issue9
dc.identifier.openalexW3080617703
dc.identifier.pubmed32838725
dc.identifier.scopus2-s2.0-85100658187
dc.identifier.startpage1099
dc.identifier.urihttps://hdl.handle.net/11421/3582
dc.identifier.urihttps://doi.org/10.2174/1871520620666200824100408
dc.identifier.volume21
dc.identifier.wos000631799700005
dc.language.isoen
dc.relation.ispartofAnti-Cancer Agents in Medicinal Chemistry
dc.rightsrestrictedAccess
dc.subjectHeLa
dc.subjectThiazole
dc.subjectTyrosine kinase
dc.subjectK562 cells
dc.subjectChemistry
dc.subjectKinase
dc.subjectJurkat cells
dc.subjectABL
dc.subjectChronic myelogenous leukemia
dc.subjectCytotoxic T cell
dc.subjectPharmacology
dc.subjectCell culture
dc.subjectIC50
dc.subjectLeukemia
dc.subjectHL60
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectStereochemistry
dc.subjectBiology
dc.subjectImmunology
dc.subjectT cell
dc.subjectSignal transduction
dc.subjectImmune system
dc.subject.sdg3
dc.titleA New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5090409393
local.authorid.openalexA5040352588
local.authorid.openalexA5048968214
local.authorid.openalexA5100651829

Dosyalar

Koleksiyonlar

Publications